Last reviewed · How we verify

NCT04604080

Post-COVID-19 Epidemic Depression Assessment in Adults in South Punjab Pakistan

Completed Last updated 19 November 2020
What this trial tests

trial testing service of questionnaire in Depression, Anxiety in 390 participants. Completed in 18 November 2020.

Timeline
1 November 2020
Primary endpoint
18 November 2020
18 November 2020

Quick facts

Lead sponsorIslamia University of Bahawalpur
StatusCompleted
Study typeOBSERVATIONAL
Enrollment390
Start date1 November 2020
Primary completion18 November 2020
Estimated completion18 November 2020
Sites5 locations across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Islamia University of Bahawalpur

Who can join

Eligibility, any sex, with Depression, Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To assess the depression in adults especially in post COVID-19 duration in the rural and urban settings.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Depression, Anxiety

Currently open trials in the same condition.

Other Islamia University of Bahawalpur trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04604080.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing